Phytomedics, a spin-off biopharmaceutical company at Rutgers, focuses on human healthcare and plant biotechnology with the goal of discovering, developing and manufacturing new plant-based pharmaceuticals, such as botanical drugs, nutraceuticals and functional foods.
The company is currently taking a series of botanical drug candidates through clinical and preclinical development. It is also engaged in the manufacture of novel therapeutic proteins in plants. Selected New Jersey farmers are growing plants containing botanical therapeutics to provide compounds used in product development by Phytomedics, Inc.
Another core area of Phytomedics' business is the plant-based production of recombinant proteins, such as antibodies, cytokines and vaccines. REPOST technology, one of the tools licensed from Rutgers, uses greenhouse-grown plants to synthesize and continuously secrete large quantities of biopharmaceutical proteins from their roots into a hydroponic solution.
Search This Site: